Literature DB >> 7516104

The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor.

G R Criscuolo1.   

Abstract

Cerebral edema and fluid-filled cysts are common accompaniments of brain tumors. They contribute to the mass effect imposed by the primary tumor and are often responsible for a patient's signs and symptoms. Cerebral edema significantly increases the morbidity associated with tumor biopsy, excision, radiation therapy, and chemotherapy. Both edema and cyst formation are thought to result from a deficiency in the blood-brain barrier, with consequent extravasation of water, electrolytes, and plasma proteins from altered tumor microvessels. The resultant expansion of the cerebral interstitial space contributes to the elevated intracranial pressure observed with brain tumors. Departure from the typical blood-brain barrier microvascular architecture may only partially explain the occurrence of edema and tumor cyst formation. Biochemical mediators have also been implicated in vascular extravasation. Vascular permeability factor or vascular endothelial growth factor (VPF/VEGF) is a protein that has recently been isolated from a variety of tumors including human brain tumors. VPFb is an extraordinarily potent inducer of both microvascular extravasation (edemagenesis) and the formation of new blood vessels (angiogenesis). Its role in tumor growth and progression would therefore appear pivotal. Herein, the author presents an updated account of the investigation of VPF. Historical and clinical perspectives of the study and treatment of tumor associated edema are provided. The efficacy of high-dose dexamethasone in the treatment of neoplastic brain edema is discussed. A hypothetical role for VPF in edemagenesis is presented and discussed. It is hoped that an expanded understanding of the mechanisms responsible for the genesis of edema will ultimately facilitate therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7516104      PMCID: PMC2588896     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  125 in total

1.  Glioblastoma multiforme; review of 219 cases with regard to natural history, pathology, diagnostic methods, and treatment.

Authors:  S A FRANKEL; W J GERMAN
Journal:  J Neurosurg       Date:  1958-09       Impact factor: 5.115

2.  Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways.

Authors:  K P Claffey; W O Wilkison; B M Spiegelman
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

Review 3.  Culture of vascular endothelium.

Authors:  M A Gimbrone
Journal:  Prog Hemost Thromb       Date:  1976

4.  Primary culture of capillary endothelium from rat brain.

Authors:  P D Bowman; A L Betz; D Ar; J S Wolinsky; J B Penney; R R Shivers; G W Goldstein
Journal:  In Vitro       Date:  1981-04

5.  Methods for microcarrier culture of bovine pulmonary artery endothelial cells avoiding the use of enzymes.

Authors:  U S Ryan; M Mortara; C Whitaker
Journal:  Tissue Cell       Date:  1980       Impact factor: 2.466

6.  Cytosolic calcium changes in endothelial cells induced by a protein product of human gliomas containing vascular permeability factor activity.

Authors:  G R Criscuolo; P I Lelkes; D Rotrosen; E H Oldfield
Journal:  J Neurosurg       Date:  1989-12       Impact factor: 5.115

7.  Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.

Authors:  Y Myoken; Y Kayada; T Okamoto; M Kan; G H Sato; J D Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

8.  CT findings and glucocorticoid receptors in intracranial lesions with edema.

Authors:  Z Y Yu; A Hatam; M Bergström; T Greitz
Journal:  J Comput Assist Tomogr       Date:  1981-10       Impact factor: 1.826

9.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

Authors:  D R Senger; C A Perruzzi; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

10.  NEW CYTOPLASMIC COMPONENTS IN ARTERIAL ENDOTHELIA.

Authors:  E R WEIBEL; G E PALADE
Journal:  J Cell Biol       Date:  1964-10       Impact factor: 10.539

View more
  22 in total

Review 1.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

2.  The Anti-Edematous Effect of Ghrelin in Brain Hypoxia is Associated with Decreasing Expression of Vascular Endothelial Growth Factor.

Authors:  Gisou Mohaddes; Jalal Abdolalizadeh; Shirin Babri; Naghi Abedini; Fezzeh Hossienzadeh
Journal:  J Mol Neurosci       Date:  2015-03-01       Impact factor: 3.444

Review 3.  Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis comparable with mechanisms seen in inflammatory pathways? Part I: historical observations and clinical perspectives on the etiology of increased CSF protein levels, CSF clotting, and communicating hydrocephalus: a comprehensive review.

Authors:  Yosef Laviv; Burkhard S Kasper; Ekkehard M Kasper
Journal:  Neurosurg Rev       Date:  2017-03-07       Impact factor: 3.042

Review 4.  Angiogenesis in brain tumors; pathobiological and clinical aspects.

Authors:  P Wesseling; D J Ruiter; P C Burger
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

Review 5.  VEGF in brain tumors.

Authors:  M R Machein; K H Plate
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

6.  VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain.

Authors:  N van Bruggen; H Thibodeaux; J T Palmer; W P Lee; L Fu; B Cairns; D Tumas; R Gerlai; S P Williams; M van Lookeren Campagne; N Ferrara
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 7.  Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis related to or comparable with mechanisms seen in inflammatory pathways? Part II: angiogenesis- and inflammation-related molecular pathways, tumor-associated macrophages, and possible therapeutic implications: a comprehensive review.

Authors:  Yosef Laviv; Burkhard Kasper; Ekkehard M Kasper
Journal:  Neurosurg Rev       Date:  2017-03-11       Impact factor: 3.042

8.  MRI of intracerebral hematoma: value of vasogenic edema ratio for predicting the cause.

Authors:  G A Tung; B D Julius; J M Rogg
Journal:  Neuroradiology       Date:  2003-05-08       Impact factor: 2.804

9.  Spatial expression of VEGF-A in human glioma.

Authors:  Mikael Johansson; Thomas Brännström; A Tommy Bergenheim; Roger Henriksson
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

Review 10.  Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis.

Authors:  W Kolch; G Martiny-Baron; A Kieser; D Marmé
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.